Year
2023
-
10.08.2013 – Viriom Reports Clinical Efficacy Data for VM1500, a New HIV NNRTI
-
Podophyllotoxin – Featured Structure of the Month
-
IRESSA® (gefitinib) Approved by the U.S. Food and Drug Administration for First-Line Treatment of Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer
-
2015 Chinese Medicinal Chemistry Symposium(CMCS2015) 5th CPA-RSC Symposium on Medicinal Chemistry in August
-
Viriom Announces Receipt of Funding from the Skolkovo Foundation, ChemRar and Torrey Pines Investment to Develop Elpida®, a Novel Preventive and Long-acting Treatment of HIV/AIDS
-
SatRx LLC Announces First Registration in Russia of SatRx® (gosogliptin), an Innovative Drug for Treatment of Type 2 Diabetes
-
ChemDiv and Insilico Medicine Form A Strategic Alliance to Develop Oncology Focused Libraries Using Artificial Intelligence
-
ChemDiv is presenting at the SCI’s event: Innovation in Design, Supply and Acquisition for Compound Screening Libraries, on 14th September 2016 in Hatfield, UK
-
Trevi Therapeutics Announces Positive Results from Phase 2 Trial in Prurigo Nodularis
-
New molecule may help fight obesity